Angiolab
Daejeon, South Korea · Founded 1999 · $7.1M raised
- Headquarters
- Daejeon
- Employees
- 11–50
- Founded
- 1999
- Business Model
- B2B
- Website
- angiolab.co.kr
- Total Funding
- $7.1M
- Last Round
- $7.1M SeedJan 2006
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
AngioLab, Inc. is a South Korean biotechnology company specializing in the discovery and development of angiogenesis inhibitors and stimulators for therapeutic applications. The company develops pharmaceutical products targeting ophthalmic disorders (including macular degeneration), gastrointestinal conditions, psoriasis, obesity, and metabolic diseases, as well as cosmetic and functional food applications. With over 102 patents and a focus on the molecular mechanisms of angiogenesis — the process of new blood vessel formation — AngioLab conducts clinical trials and partners with pharmaceutical companies to advance its pipeline. The company is publicly listed on the Korean KOSDAQ exchange (stock symbol: 251280) and is headquartered in Daejeon, South Korea (Yuseong-gu district). Its research spans angiogenesis modulation across both inhibitory (cancer, AMD) and stimulatory (wound healing, ischemia) therapeutic axes.
Summary
Angiolab is a Biotech company based in Daejeon, South Korea, founded in 1999. It has raised $7.1M in total across 1 round, most recently a $7.1M Seed round in Jan 2006. Investors include Korean Development Bank.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2006
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/angiolab"><img src="https://indexed.vc/api/badge/company/angiolab" alt="Angiolab on Indexed.vc" width="260" height="76" /></a>